A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

OBJECTIVES: To assess the efficacy of the interleukin 1 receptor antagonist anakinra in systemic-onset juvenile idiopathic arthritis (SJIA). METHODS: A multicentre, randomised, double-blind, placebo-controlled trial was conducted. The primary objective was to compare the efficacy of a 1-month treatm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Quartier, Pierre, Allantaz, Florence, Cimaz, Rolando, Pillet, Pascal, Messiaen, Claude, Bardin, Christophe, Bossuyt, Xavier, Boutten, Anne, Bienvenu, Jacques, Duquesne, Agnes, Richer, Olivier, Chaussabel, Damien, Mogenet, Agnes, Banchereau, Jacques, Treluyer, Jean-Marc, Landais, Paul, Pascual, Virginia
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2010
Soggetti:
Clinical and Epidemiological Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070271/
https://ncbi.nlm.nih.gov/pubmed/21173013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.134254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi